Back to search

Article

Design and Molecular Simulation of a Rituximab-Methimazole Hybrid Compound for Selective Thyroid-Stimulating Hormone Receptor Inhibition in Graves’ Disease

2025-07-22

Abstract excerpt

<h4>Introduction: </h4> Graves' disease (GD), an autoimmune disorder characterized by hyperthyroidism and the production of autoantibodies targeting the thyroid-stimulating hormone receptor (TSHR), poses a considerable challenge in clinical management. Antithyroid medications block thyroid hormone synthesis and are usually the first-line treatment. In recent years, the advent of computational compound design has o...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
331928d5-5429-5ff0-a883-8cb62de8e8bd
DOI
10.1590/scielopreprints.12615
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Design and Molecular Simulation of a Rituximab-Methimazole Hybrid Compound for Selective Thyroid-Stimulating Hormone Receptor Inhibition in Graves’ DiseaseDOI 10.1590/scielopreprints.12615
Select a neighboring publication to make it the new centre.